Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas

Abstract Lymphoma is the most common type of canine hematological malignancy where the multicentric (cMCL) form accounts for 75% of all cases. The standard treatment is the CHOP chemotherapy protocols that include cyclophosphamide, doxorubicin, vincristine and prednisone, where the majority of dogs...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Taismara K. Garnica, Jéssika C. C. Lesbon, Ana C. F. C. M. Ávila, Arina L. Rochetti, Oscar R. S. Matiz, Roana C. S. Ribeiro, Aline Zoppa, Adriana T. Nishiya, Mirela T. Costa, Andrigo B. de Nardi, David J. Argyle, Ricardo F. Strefezzi, Juliano C. Silveira, Heidge Fukumasu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7f611e4eb68c40a7851795778365a7f3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7f611e4eb68c40a7851795778365a7f3
record_format dspace
spelling oai:doaj.org-article:7f611e4eb68c40a7851795778365a7f32021-12-02T12:33:52ZLiquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas10.1038/s41598-020-77366-72045-2322https://doaj.org/article/7f611e4eb68c40a7851795778365a7f32020-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-77366-7https://doaj.org/toc/2045-2322Abstract Lymphoma is the most common type of canine hematological malignancy where the multicentric (cMCL) form accounts for 75% of all cases. The standard treatment is the CHOP chemotherapy protocols that include cyclophosphamide, doxorubicin, vincristine and prednisone, where the majority of dogs achieve complete/partial response; however, it is very important to predict non-responsive cases to improve treatment and to develop new targeted therapies. Here we evaluate a liquid biopsy approach based on serum Small Extracellular Vesicles enriched for exosomes (SEVs) to predict cMCL chemotherapy response. Nineteen dogs at the end of the 19-week chemotherapy protocol (8 Complete Response and 11 Progressive Disease) were evaluated for serum SEVs size, concentration and screened for 95 oncomirs. PD patients had higher SEVs concentration at the diagnosis than CR patients (P = 0.034). The ROC curve was significant for SEVs concentration to predict the response to CHOP (AUC = 0.8011, P = 0.0287). A potential molecular signature based on oncomirs from SEVs (caf-miR-205, caf-miR-222, caf-mir-20a and caf-miR-93) is proposed. To the best of our knowledge, this is the first study demonstrating the potential of a liquid biopsy based on SEVs and their miRNAs content to predict the outcome of chemotherapy for canine multicentric lymphomas.Taismara K. GarnicaJéssika C. C. LesbonAna C. F. C. M. ÁvilaArina L. RochettiOscar R. S. MatizRoana C. S. RibeiroAline ZoppaAdriana T. NishiyaMirela T. CostaAndrigo B. de NardiDavid J. ArgyleRicardo F. StrefezziJuliano C. SilveiraHeidge FukumasuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Taismara K. Garnica
Jéssika C. C. Lesbon
Ana C. F. C. M. Ávila
Arina L. Rochetti
Oscar R. S. Matiz
Roana C. S. Ribeiro
Aline Zoppa
Adriana T. Nishiya
Mirela T. Costa
Andrigo B. de Nardi
David J. Argyle
Ricardo F. Strefezzi
Juliano C. Silveira
Heidge Fukumasu
Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas
description Abstract Lymphoma is the most common type of canine hematological malignancy where the multicentric (cMCL) form accounts for 75% of all cases. The standard treatment is the CHOP chemotherapy protocols that include cyclophosphamide, doxorubicin, vincristine and prednisone, where the majority of dogs achieve complete/partial response; however, it is very important to predict non-responsive cases to improve treatment and to develop new targeted therapies. Here we evaluate a liquid biopsy approach based on serum Small Extracellular Vesicles enriched for exosomes (SEVs) to predict cMCL chemotherapy response. Nineteen dogs at the end of the 19-week chemotherapy protocol (8 Complete Response and 11 Progressive Disease) were evaluated for serum SEVs size, concentration and screened for 95 oncomirs. PD patients had higher SEVs concentration at the diagnosis than CR patients (P = 0.034). The ROC curve was significant for SEVs concentration to predict the response to CHOP (AUC = 0.8011, P = 0.0287). A potential molecular signature based on oncomirs from SEVs (caf-miR-205, caf-miR-222, caf-mir-20a and caf-miR-93) is proposed. To the best of our knowledge, this is the first study demonstrating the potential of a liquid biopsy based on SEVs and their miRNAs content to predict the outcome of chemotherapy for canine multicentric lymphomas.
format article
author Taismara K. Garnica
Jéssika C. C. Lesbon
Ana C. F. C. M. Ávila
Arina L. Rochetti
Oscar R. S. Matiz
Roana C. S. Ribeiro
Aline Zoppa
Adriana T. Nishiya
Mirela T. Costa
Andrigo B. de Nardi
David J. Argyle
Ricardo F. Strefezzi
Juliano C. Silveira
Heidge Fukumasu
author_facet Taismara K. Garnica
Jéssika C. C. Lesbon
Ana C. F. C. M. Ávila
Arina L. Rochetti
Oscar R. S. Matiz
Roana C. S. Ribeiro
Aline Zoppa
Adriana T. Nishiya
Mirela T. Costa
Andrigo B. de Nardi
David J. Argyle
Ricardo F. Strefezzi
Juliano C. Silveira
Heidge Fukumasu
author_sort Taismara K. Garnica
title Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas
title_short Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas
title_full Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas
title_fullStr Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas
title_full_unstemmed Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas
title_sort liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/7f611e4eb68c40a7851795778365a7f3
work_keys_str_mv AT taismarakgarnica liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT jessikacclesbon liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT anacfcmavila liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT arinalrochetti liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT oscarrsmatiz liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT roanacsribeiro liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT alinezoppa liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT adrianatnishiya liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT mirelatcosta liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT andrigobdenardi liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT davidjargyle liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT ricardofstrefezzi liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT julianocsilveira liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
AT heidgefukumasu liquidbiopsybasedonsmallextracellularvesiclespredictschemotherapyresponseofcaninemulticentriclymphomas
_version_ 1718393868852920320